Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012) (2022)

Prevalence of transmitted drug resistance (pTDR) to antiretroviral drugs in Spain (2007-2012) was estimated using the CoRIS cohort, adjusting its territorial distribution and transmission route to the reference population from the Spanish Information System on New human immunodeficiency virus diagnoses. A total of 2702 patients from ten autonomous communities and with naive FASTA sequence within 6 months of human immunodeficiency virus diagnosis were selected. Weighted pTDR, estimated using the inverse probability of selection in the sample by autonomous communities and transmission group, was 8.12% (95% CI 6.44-9.80), not significantly different from unweighted pTDR. We illustrate how proportional weighting can maximize representativeness of cohort-based data, and its value to monitor pTDR at country level.

Original languageEnglish
Pages (from-to)105.e1-105.e5
JournalClinical Microbiology and Infection
Volume21
Issue number1
DOIs
StatePublished - 2015
  • Antiretroviral agents
  • Cohort studies
  • Drug resistance
  • Epidemiological monitoring
  • Human immunodeficiency virus
  • APA
  • Author
  • BIBTEX
  • Harvard
  • Standard
  • RIS
  • Vancouver

Cohorte de la Red de Investigación en Sida (CoRIS) (2015). Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012). Clinical Microbiology and Infection, 21(1), 105.e1-105.e5. https://doi.org/10.1016/j.cmi.2014.08.007

Cohorte de la Red de Investigación en Sida (CoRIS). / Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012). In: Clinical Microbiology and Infection. 2015 ; Vol. 21, No. 1. pp. 105.e1-105.e5.

@article{f63f7ff0574542298461f9a4784a3722,

title = "Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)",

abstract = "Prevalence of transmitted drug resistance (pTDR) to antiretroviral drugs in Spain (2007-2012) was estimated using the CoRIS cohort, adjusting its territorial distribution and transmission route to the reference population from the Spanish Information System on New human immunodeficiency virus diagnoses. A total of 2702 patients from ten autonomous communities and with naive FASTA sequence within 6 months of human immunodeficiency virus diagnosis were selected. Weighted pTDR, estimated using the inverse probability of selection in the sample by autonomous communities and transmission group, was 8.12% (95% CI 6.44-9.80), not significantly different from unweighted pTDR. We illustrate how proportional weighting can maximize representativeness of cohort-based data, and its value to monitor pTDR at country level.",

(Video) Conceptualizing Care Continua

keywords = "Antiretroviral agents, Cohort studies, Drug resistance, Epidemiological monitoring, Human immunodeficiency virus",

author = "{Cohorte de la Red de Investigaci{\'o}n en Sida (CoRIS)} and S. Monge and M. D{\'i}ez and M. Alvarez and V. Guillot and Iribarren, {J. A.} and R. Palacios and R. Delgado and A. Ja{\'e}n and Blanco, {J. R.} and P. Domingo and J. Portilla and {P{\'e}rez El{\'i}as}, {M. J.} and F. Garcia and {del Amo}, Julia and Federico Garc{\'i}a and Mu{\~n}oz, {Mar{\'i}a {\'A}ngeles} and Vegas, {Paz Sobrino} and Sebasti{\'a}n, {Victoria Hernando} and Ferreras, {Bel{\'e}n Alejos} and D{\'e}bora {\'A}lvarez and Inma Jarr{\'i}n and Mu{\~n}oz-Fern{\'a}ndez, {M. {\'A}ngeles} and Isabel Garc{\'i}a-Merino and Rico, {Coral G{\'o}mez} and {de la Fuente}, {Jorge Gallego} and Torre, {Almudena Garc{\'i}a} and {de Lucas}, {Esperanza Merino} and Ba{\~n}uls, {Sergio Reus} and Mart{\'i}nez, {Vicente Boix} and Oncina, {Livia Giner} and Pastor, {Carmen Gadea} and Tamarit, {Irene Portilla} and Toledo, {Patricia Arcaina} and Victor Asensi and Eulalia Valle and Cart{\'o}n, {Jos{\'e} Antonio} and Sirvent, {Juan Luis G{\'o}mez} and Fort{\'u}nez, {Patricia Rodr{\'i}guez} and Valls, {Mar{\'i}a Remedios Alem{\'a}n} and Socas, {Mar{\'i}a del Mar Alonso} and Hern{\'a}ndez, {Mar{\'i}a Inmaculada Hern{\'a}ndez} and Felicitas D{\'i}az-Flores and Rosado, {D{\'a}cil Garc{\'i}a} and Gonz{\'a}lez, {Ricardo Pelazas} and Vicente Soriano and Pablo Labarga and Pablo Barreiro and Francisco Blanco and Carbonero, {Luz Mart{\'i}n} and Laura Ib{\'a}{\~n}ez",

note = "Funding Information: The RIS cohort (CoRIS) is funded by the Instituto de Salud Carlos III through the Red Tem{\'a}tica de Investigaci{\'o}n Cooperativa en Sida ( ISCIII-RETIC RD06/0006/0026 ). This work was also partially funded by ISCIII Grant no. PI12/01053 . Publisher Copyright: {\textcopyright} 2014 European Society of Clinical Microbiology and Infectious Diseases.",

year = "2015",

doi = "10.1016/j.cmi.2014.08.007",

language = "English",

volume = "21",

pages = "105.e1--105.e5",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

number = "1",

}

Cohorte de la Red de Investigación en Sida (CoRIS) 2015, 'Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)', Clinical Microbiology and Infection, vol. 21, no. 1, pp. 105.e1-105.e5. https://doi.org/10.1016/j.cmi.2014.08.007

Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012). / Cohorte de la Red de Investigación en Sida (CoRIS).

In: Clinical Microbiology and Infection, Vol. 21, No. 1, 2015, p. 105.e1-105.e5.

Research output: Contribution to journalArticlepeer-review

TY - JOUR

T1 - Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

AU - Cohorte de la Red de Investigación en Sida (CoRIS)

(Video) Student Mistreatment: Scope, Impact and Possible Solutions

AU - Monge, S.

AU - Díez, M.

AU - Alvarez, M.

AU - Guillot, V.

AU - Iribarren, J. A.

AU - Palacios, R.

AU - Delgado, R.

AU - Jaén, A.

AU - Blanco, J. R.

AU - Domingo, P.

AU - Portilla, J.

AU - Pérez Elías, M. J.

AU - Garcia, F.

AU - del Amo, Julia

AU - García, Federico

AU - Muñoz, María Ángeles

AU - Vegas, Paz Sobrino

AU - Sebastián, Victoria Hernando

AU - Ferreras, Belén Alejos

AU - Álvarez, Débora

AU - Jarrín, Inma

AU - Muñoz-Fernández, M. Ángeles

AU - García-Merino, Isabel

AU - Rico, Coral Gómez

AU - de la Fuente, Jorge Gallego

(Video) Screening &Treating Chlamydia in Primary Care

AU - Torre, Almudena García

AU - de Lucas, Esperanza Merino

AU - Bañuls, Sergio Reus

AU - Martínez, Vicente Boix

AU - Oncina, Livia Giner

AU - Pastor, Carmen Gadea

AU - Tamarit, Irene Portilla

AU - Toledo, Patricia Arcaina

AU - Asensi, Victor

AU - Valle, Eulalia

AU - Cartón, José Antonio

AU - Sirvent, Juan Luis Gómez

AU - Fortúnez, Patricia Rodríguez

AU - Valls, María Remedios Alemán

AU - Socas, María del Mar Alonso

AU - Hernández, María Inmaculada Hernández

AU - Díaz-Flores, Felicitas

AU - Rosado, Dácil García

AU - González, Ricardo Pelazas

AU - Soriano, Vicente

AU - Labarga, Pablo

AU - Barreiro, Pablo

AU - Blanco, Francisco

AU - Carbonero, Luz Martín

AU - Ibáñez, Laura

(Video) HIV and Hepatitis Co-infections in Adolescents and Women: Progress and Pitfalls

N1 - Funding Information:The RIS cohort (CoRIS) is funded by the Instituto de Salud Carlos III through the Red Temática de Investigación Cooperativa en Sida ( ISCIII-RETIC RD06/0006/0026 ). This work was also partially funded by ISCIII Grant no. PI12/01053 . Publisher Copyright:© 2014 European Society of Clinical Microbiology and Infectious Diseases.

PY - 2015

Y1 - 2015

N2 - Prevalence of transmitted drug resistance (pTDR) to antiretroviral drugs in Spain (2007-2012) was estimated using the CoRIS cohort, adjusting its territorial distribution and transmission route to the reference population from the Spanish Information System on New human immunodeficiency virus diagnoses. A total of 2702 patients from ten autonomous communities and with naive FASTA sequence within 6 months of human immunodeficiency virus diagnosis were selected. Weighted pTDR, estimated using the inverse probability of selection in the sample by autonomous communities and transmission group, was 8.12% (95% CI 6.44-9.80), not significantly different from unweighted pTDR. We illustrate how proportional weighting can maximize representativeness of cohort-based data, and its value to monitor pTDR at country level.

AB - Prevalence of transmitted drug resistance (pTDR) to antiretroviral drugs in Spain (2007-2012) was estimated using the CoRIS cohort, adjusting its territorial distribution and transmission route to the reference population from the Spanish Information System on New human immunodeficiency virus diagnoses. A total of 2702 patients from ten autonomous communities and with naive FASTA sequence within 6 months of human immunodeficiency virus diagnosis were selected. Weighted pTDR, estimated using the inverse probability of selection in the sample by autonomous communities and transmission group, was 8.12% (95% CI 6.44-9.80), not significantly different from unweighted pTDR. We illustrate how proportional weighting can maximize representativeness of cohort-based data, and its value to monitor pTDR at country level.

KW - Antiretroviral agents

KW - Cohort studies

KW - Drug resistance

KW - Epidemiological monitoring

KW - Human immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=84926285901&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2014.08.007

DO - 10.1016/j.cmi.2014.08.007

M3 - Article

C2 - 25636937

AN - SCOPUS:84926285901

VL - 21

SP - 105.e1-105.e5

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 1

ER -

Cohorte de la Red de Investigación en Sida (CoRIS). Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012). Clinical Microbiology and Infection. 2015;21(1):105.e1-105.e5. https://doi.org/10.1016/j.cmi.2014.08.007

(Video) Stefan Baral: Risks, Vulnerabilities & the Burden of Living with HIV

Videos

1. Webinar: Hepatocellular Carcinoma and HCV Cure with DAAs
(American Liver Foundation)
2. The new high risk populations: Who are they?
(IAC - the International AIDS Conference)
3. Antiretroviral Therapy - ART: Season One
(IAS Conference on HIV Science)
4. RISC - Research & Informatics Service Center
(CCTS)
5. Going the extra mile to Eliminate Hepatitis C in the Hispanic/Latino Communities
(HHS Office of Minority Health)
6. When TB is the Least of Their Worries: Immigration
(SNTCWebinars)

Top Articles

You might also like

Latest Posts

Article information

Author: Patricia Veum II

Last Updated: 09/02/2022

Views: 6033

Rating: 4.3 / 5 (44 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Patricia Veum II

Birthday: 1994-12-16

Address: 2064 Little Summit, Goldieton, MS 97651-0862

Phone: +6873952696715

Job: Principal Officer

Hobby: Rafting, Cabaret, Candle making, Jigsaw puzzles, Inline skating, Magic, Graffiti

Introduction: My name is Patricia Veum II, I am a vast, combative, smiling, famous, inexpensive, zealous, sparkling person who loves writing and wants to share my knowledge and understanding with you.